tests not peer reviewed preprint joyner colleagues published medrxiv 30 july compiles data 800 participants dozen studies hope boosting statistical power team found treatment cut mortality 26 13 difficult draw firm conclusion data combined disparate studies cautions josephson trials treated people varying disease severity different doses plasma tracking range measures success lot things pick apart analysis says josephson time not value safety data data come united kingdom epidemiologist martin landray infectious disease researcher peter horby university oxford leading large recovery trial testing therapies including convalescent plasma people hospitalized covid-19 gordon colleagues testing convalescent plasma people intensive care international trial called